Gene · 5499
Papers4,146
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,146
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Resolution Substrate Specificity Profiling of SARS-CoV-2 Mpro; Comparison to SARS-CoV Mpro. | ACS Chem Biol | 2024 | 38865301 | PubTator, text mining | PubMed |
| Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer. | Breast Cancer Res | 2024 | 38831458 | PubTator, text mining | PubMed |
| The Aurora B-controlled PP1/RepoMan complex determines the spatial and temporal distribution of mitotic H2B S6 phosphorylation. | Open Biol | 2024 | 38806145 | PubTator, text mining | PubMed |
| Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 main protease using a linked protein FRET platform. | J Biol Chem | 2024 | 38750796 | PubTator, text mining | PubMed |
| PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway. | Carcinogenesis | 2024 | 38715543 | PubTator, text mining | PubMed |
| CK1 and PP1 regulate Rift Valley fever virus genome replication through L protein phosphorylation. | Antiviral Res | 2024 | 38679165 | PubTator, text mining | PubMed |
| Impact of Protein Phosphatase Expressions on the Prognosis of Hepatocellular Carcinoma Patients. | ACS Omega | 2024 | 38463290 | PubTator, text mining | PubMed |
| Circulating tumor cell clustering modulates RNA splicing and polyadenylation to facilitate metastasis. | Cancer Lett | 2024 | 38417668 | PubTator, text mining | PubMed |
| The Main Protease of Middle East Respiratory Syndrome Coronavirus Induces Cleavage of Mitochondrial Antiviral Signaling Protein to Antagonize the Innate Immune Response. | Viruses | 2024 | 38400032 | PubTator, text mining | PubMed |
| A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway. | Mol Cancer | 2024 | 38360682 | PubTator, text mining | PubMed |
| Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools. | Int J Mol Sci | 2024 | 38339078 | PubTator, text mining | PubMed |
| Crosstalk of HDAC4, PP1, and GSDMD in controlling pyroptosis. | Cell Death Dis | 2024 | 38326336 | PubTator, text mining | PubMed |
| Challenges in distinguishing functional proteins from polyproteins in databases: implications for drug discovery. | Brief Bioinform | 2024 | 38305454 | PubTator, text mining | PubMed |
| Recent advances in chemometric modelling of inhibitors against SARS-CoV-2. | Heliyon | 2024 | 38293468 | PubTator, text mining | PubMed |
| Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review. | World J Gastrointest Oncol | 2024 | 38292842 | PubTator, text mining | PubMed |
| Antivirals for Broader Coverage against Human Coronaviruses. | Viruses | 2024 | 38275966 | PubTator, text mining | PubMed |
| Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. | Cells | 2024 | 38275816 | PubTator, text mining | PubMed |
| Genotype and phenotype correlation of PHACTR1-related neurological disorders. | J Med Genet | 2024 | 38272663 | PubTator, text mining | PubMed |
| Emerging roles of the Protein Phosphatase 1 (PP1) in the context of viral infections. | Cell Commun Signal | 2024 | 38267954 | PubTator, text mining | PubMed |
| Mutation of a highly conserved isoleucine residue in loop 2 of several β-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental to infection. | bioRxiv | 2024 | 38260573 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5499/papers?page=4